Tag: Serranator

Sectoral Asset Management makes US$9 million investment into Cagent Vascular

Cagent Vascular recently announced the investment of US$9 million by Sectoral Asset Management. Along with the investment, Marc-Andre Marcotte has joined the board of...

LINC 2021: PRELUDE-BTK results confirm Serranator device novel mechanism of action

Cagent Vascular announced the results of its PRELUDE-BTK study at LINC 2021 (25–29 January, online). The PRELUDE-BTK study was a prospective, single-arm, multicentre feasibility...